Yao Yaqi, Xu Zhenna, Ding Haoran, Yang Shenshen, Chen Bohan, Zhou Mengjiao, Zhu Yehan, Yang Aihong, Yan Xingxu, Liang Chenrui, Kou Xiaodi, Chen Bo, Huang Wei, Li Yubo
National Key Laboratory of Chinese Medicine Modernization, State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
J Nanobiotechnology. 2025 Feb 14;23(1):108. doi: 10.1186/s12951-025-03146-y.
There are abundant natural products resources and extensive clinical use experience in China. However, the active components of natural products generally have problems such as poor water solubility and low bioavailability, which limit their druggability. Carrier-free nanoparticles, such as nanocrystals, self-assembled nanoparticles, and extracellular vesicles derived from both animal and plant sources, have great application potential in improving the safety and efficacy of drugs due to their simple and flexible preparation methods, high drug loading capacity and delivery efficiency, as well as long half-life in blood circulation. It has been widely used in biomedical fields such as anti-tumor, anti-bacterial, anti-inflammatory and anti-oxidation. Therefore, based on the natural products that have been used in clinic, this review focuses on the advantages of carrier-free nanoparticles in delivering active compounds, in order to improve the delivery process of natural products in vivo and improve their draggability.
中国拥有丰富的天然产物资源和广泛的临床应用经验。然而,天然产物的活性成分通常存在水溶性差和生物利用度低等问题,这限制了它们的成药可能性。无载体纳米颗粒,如纳米晶体、自组装纳米颗粒以及来自动物和植物来源的细胞外囊泡,由于其制备方法简单灵活、载药量和递送效率高以及在血液循环中的半衰期长,在提高药物的安全性和有效性方面具有巨大的应用潜力。它已广泛应用于抗肿瘤、抗菌、抗炎和抗氧化等生物医学领域。因此,基于已在临床上使用的天然产物,本综述重点介绍无载体纳米颗粒在递送活性化合物方面的优势,以改善天然产物在体内的递送过程并提高其成药可能性。
J Nanobiotechnology. 2025-2-14
ACS Appl Mater Interfaces. 2020-9-23
Int J Nanomedicine. 2024
Biomater Sci. 2024-12-3
Curr Drug Deliv. 2023
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024
Expert Opin Drug Deliv. 2017-6
Adv Sci (Weinh). 2025-8
Molecules. 2024-7-15